Mesothelioma Science News
San Pedro, CA - September 18, 2007
1. Two substances that induce cell death in pleural
mesothelioma are promising candidates for local treatment
within multimodality treatment plans.
Link here.
2. Anti-mesothelin immunotoxin shows promise and is slated
for Phase II clinical trial for mesothelioma patients.
Link here.
3. Using thoracoscopy under local anesthesia rather than
general anesthesia is recommended as a diagnostic procedure
for cases with pleural diseases.
Link here.
4. The export of Canadian asbestos to developing countries
sets the stage for another preventable occupational disease
epidemic that will manifest over the coming decades.
Link here.
5. Mesothelioma increasing in Australia, along with the
mean latency and number of "non-occupational"
cases.
Link here.
6. Radiotherapy and intraperitoneal paclitaxel suitable in
palliative settings to improve the quality of life in
advanced peritoneal mesothelioma.
Link here.
7. Phase II testing of sunitinib, an inhibitor that affects
tumour proliferation and angiogenesis in cancers including
mesothelioma.
Link here.
8. Disrupting angiogenesis mediated by malignant
mesothelioma cells.
Link here.
9. Possible chemotherapy role for activated and
latent signal transducer and activator of transcription 3
in mesothelioma cases.
Link here.
10. Phase II trials planned for recombinant anti-mesothelin
immunotoxin for malignant mesothelioma patients.
Link here.
11. Serum mesothelin is a promising marker for the
diagnosis, prognosis, and clinical monitoring of malignant
mesothelioma.
Link here.
12. Multivitamin/mineral supplement use and its effect on
cancer prevention.
Link here.
13. Pericardial mesothelioma patient with metastases to
liver responds well to pemetrexed and carboplatin-based
combination chemotherapy.
Link here.
14. Combination of radiotherapy and intraperitoneal
paclitaxel suitable in palliative settings aimed at
improving the quality of life.
Link here.
15. Flow cytometric immunophenotyping is an effective
method for characterizing cancer cells in clinical effusion
specimens and is comparable to immunohistochemistry in
terms of sensitivity and specificity.
Link here.
16. Intraoperative chemotherapy with heat benefits patients
with peritoneal and pleural mesothelioma.
Link here.